Back to Search
Start Over
Cytomed Therapeutics announces NMRC co-funding support for ANGELICA trial
- Source :
- The Fly. October 7, 2024
- Publication Year :
- 2024
-
Abstract
- CytoMed Therapeutics has obtained full approval for its first-in-human Phase I clinical trial using its patented allogeneic chimeric antigen receptor T cell against several blood and solid tumors in collaboration [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.811439448